Free Trial
NYSE:TFX

Teleflex (TFX) Stock Price, News & Analysis

Teleflex logo
$140.24 +3.98 (+2.92%)
Closing price 03/7/2025 03:59 PM Eastern
Extended Trading
$139.40 -0.85 (-0.61%)
As of 03/7/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Teleflex Stock (NYSE:TFX)

Key Stats

Today's Range
$135.05
$140.31
50-Day Range
$130.87
$183.81
52-Week Range
$128.55
$249.90
Volume
1.13 million shs
Average Volume
822,819 shs
Market Capitalization
$6.50 billion
P/E Ratio
27.88
Dividend Yield
0.97%
Price Target
$182.63
Consensus Rating
Hold

Company Overview

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Remove Ads

Teleflex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
95th Percentile Overall Score

TFX MarketRank™: 

Teleflex scored higher than 95% of companies evaluated by MarketBeat, and ranked 40th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Teleflex has received a consensus rating of Hold. The company's average rating score is 2.09, and is based on 2 buy ratings, 8 hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Teleflex has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Teleflex's stock forecast and price target.
  • Earnings Growth

    Earnings for Teleflex are expected to grow by 8.58% in the coming year, from $13.98 to $15.18 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Teleflex is 27.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.86.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Teleflex is 27.88, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.18.

  • Price to Earnings Growth Ratio

    Teleflex has a PEG Ratio of 1.73. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Teleflex has a P/B Ratio of 1.48. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Teleflex's valuation and earnings.
  • Percentage of Shares Shorted

    2.66% of the float of Teleflex has been sold short.
  • Short Interest Ratio / Days to Cover

    Teleflex has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teleflex has recently increased by 6.96%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Teleflex pays a meaningful dividend of 1.04%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Teleflex does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Teleflex is 95.77%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Teleflex will have a dividend payout ratio of 8.96% next year. This indicates that Teleflex will be able to sustain or increase its dividend.

  • Read more about Teleflex's dividend.
  • Percentage of Shares Shorted

    2.66% of the float of Teleflex has been sold short.
  • Short Interest Ratio / Days to Cover

    Teleflex has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Teleflex has recently increased by 6.96%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Teleflex has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 40 news articles for Teleflex this week, compared to 9 articles on an average week.
  • Search Interest

    5 people have searched for TFX on MarketBeat in the last 30 days. This is an increase of 25% compared to the previous 30 days.
  • MarketBeat Follows

    11 people have added Teleflex to their MarketBeat watchlist in the last 30 days. This is an increase of 57% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Teleflex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.43% of the stock of Teleflex is held by insiders.

  • Percentage Held by Institutions

    95.62% of the stock of Teleflex is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Teleflex's insider trading history.
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

TFX Stock News Headlines

Q2 Earnings Forecast for Teleflex Issued By Zacks Research
Has Trump finally met his match?
Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?
Teleflex (NYSE:TFX) Rating Lowered to Underperform at Bank of America
See More Headlines

TFX Stock Analysis - Frequently Asked Questions

Teleflex's stock was trading at $177.98 on January 1st, 2025. Since then, TFX shares have decreased by 21.2% and is now trading at $140.2440.
View the best growth stocks for 2025 here
.

Teleflex Incorporated (NYSE:TFX) announced its earnings results on Thursday, February, 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The medical technology company earned $795.40 million during the quarter, compared to analysts' expectations of $813.24 million. Teleflex had a trailing twelve-month return on equity of 14.19% and a net margin of 7.85%.
Read the conference call transcript
.

Teleflex's top institutional investors include T. Rowe Price Investment Management Inc. (13.29%), Vanguard Group Inc. (11.94%), Janus Henderson Group PLC (11.32%) and Geode Capital Management LLC (2.45%). Insiders that own company stock include Liam Kelly, Thomas E Powell, Cameron P Hicks and Stuart A Randle.
View institutional ownership trends
.

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Teleflex investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Tesla (TSLA), Home Depot (HD), Advanced Micro Devices (AMD) and Netflix (NFLX).

Company Calendar

Ex-Dividend for 12/16 Dividend
11/15/2024
Dividend Payable
12/16/2024
Last Earnings
2/27/2025
Ex-Dividend for 3/17 Dividend
3/07/2025
Today
3/09/2025
Dividend Payable
3/17/2025
Next Earnings (Estimated)
5/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:TFX
Employees
14,500
Year Founded
1943

Price Target and Rating

Average Stock Price Target
$182.63
High Stock Price Target
$290.00
Low Stock Price Target
$140.00
Potential Upside/Downside
+30.2%
Consensus Rating
Hold
Rating Score (0-4)
2.09
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
27.88
Forward P/E Ratio
10.03
P/E Growth
1.73
Net Income
$356.33 million
Pretax Margin
8.67%

Debt

Sales & Book Value

Annual Sales
$3.05 billion
Cash Flow
$15.08 per share
Price / Cash Flow
9.30
Book Value
$94.49 per share
Price / Book
1.48

Miscellaneous

Free Float
45,780,000
Market Cap
$6.50 billion
Optionable
Optionable
Beta
1.21

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NYSE:TFX) was last updated on 3/9/2025 by MarketBeat.com Staff
From Our Partners